Wall Street Fundamentals Releases New In-Depth Stock Reports on ASTM, ENTA, IMMU and XNPT


Follow this company

Companies Mentioned

NASDAQ:ASTM / NASDAQ:ENTA / NASDAQ:IMMU / NASDAQ:XNPT
04/11/2014 [ACCESSWIRE]

U.S. markets were dragged lowered Thursday by a continued sell-off in the Biotech and Technology Sectors. The S&P 500 Index declined 2.09 percent to close at 1,833.08, while the Nasdaq Composite Index fell 3.10 percent, the most since 2011, to settle at 4,054.11. "There’s still a continual rotation out of the high-flying momentum stocks of 2013 into more value-driven opportunities," said Stifel Nicolaus portfolio manager Chad Morganlander. "This will continue in the coming weeks as investors look for consistency in earnings. You have concerns about high valuations and flat revenue growth, which is a perfect cocktail for a sector rotation out of growth and into value." Here is how some Biotech companies reacted Thursday:

Aastrom Biosciences Inc. (NASDAQ: ASTM) shares traded in the range of $3.85 to $4.30 Thursday before settling to close at $3.89, a decrease of 9.11 percent. The stock appears to be facing some resistance at the $4.35 and $4.50 levels with some support at $4.21 and $3.62. Shares of Aastrom Biosciences have gained approximately 20.0 percent year-to-date.

More information on Aastrom Biosciences and access to the free equity report can be found at: 
www.WallStreetFundamentals.com/ASTM

Enanta Pharmaceuticals Inc. (NASDAQ: ENTA) shares traded in the range of $33.04 to $36.51 Thursday before settling to close at $33.31, a decrease of 9.14 percent. The stock appears to be facing some resistance at the $37.72 and $39.67 levels with some support at $35.94 and $33.86. Shares of Enanta Pharmaceuticals are up approximately 22.0 percent year-to-date.

More information on Enanta Pharmaceuticals and access to the free equity report can be found at: 
www.WallStreetFundamentals.com/ENTA

Immunomedics, Inc. (NASDAQ: IMMU) shares traded in the range of $3.92 to $4.48 Thursday before settling to close at $3.99, a decrease of 8.49 percent. The stock appears to be facing some resistance at the $4.42 and $4.57 levels with some support at $3.86 and $3.57. Shares of Immunomedics are down approximately 13.0 percent year-to-date.

More information on Immunomedics and access to the free equity report can be found at:      
www.WallStreetFundamentals.com/IMMU

XenoPort, Inc. (NASDAQ: XNPT) shares traded in the range of $4.37 to $4.95 Thursday before settling to close at $4.47, a decrease of 8.02 percent. The stock appears to be facing some resistance at the $4.77, $4.89 and $5.01 levels. Shares of XenoPort have fallen approximately 22.0 percent year-to-date.

More information on XenoPort and access to the free equity report can be found at: 
www.WallStreetFundamentals.com/XNPT

Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.

Activate your always free membership by signing up at www.WallStreetFundamentals.com today.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Wall Street Fundamentals
Website: www.WallStreetFundamentals.com
Email: editor@wallstreetfundamentals.com

COMMENTS

Leave a comment...
 * 

Your Name
 *